Literature DB >> 33387246

MicroRNA-596 is epigenetically inactivated and suppresses prostatic cancer cell growth and migration via regulating Wnt/β-catenin signaling.

J Dai1, G Yuan1, Y Li1, H Zhou2.   

Abstract

OBJECTIVES: Although studies have reported that miR-596 extensively participates in multiple cancer progression, the biological mechanisms and effects of miR-596 in prostatic cancer remain unclear. The literature is aimed to reveal the function and possible molecular mechanisms of miR-596 in prostatic cancer carcinogenesis.
MATERIALS AND METHODS: qRT-PCR was applied to examine miR-596 expression in prostatic cancer cell lines and samples, also methylation-specific PCR was used to detect the methylation status of the promoter CpG islands in prostatic cancer samples. Meanwhile, the tumor-related effects of miR-596 were detected via cell viability, clone formation assay, migration assay, flow cytometric and AO/EB assay. qRT-PCR and Western blots were applied to investigate the function of miR-596 on malignant behavior in prostatic cancer cells.
RESULTS: We found that miR-596 mRNA was decreased in prostatic cancer samples and cell lines. miR-596 mRNA level was also correlated to cancer stage, Gleason scores, while miR-596 promoter methylation was related to cancer tumor stage, Gleason score and preoperative PSA levels. miR-596 inhibited the cell growth and activity by causing cell apoptosis, and also suppressed the migration of prostatic cancer cells by revealing the epithelial-mesenchymal transition process. In addition, Western blot indicates that miR-596 overexpression deregulated Wnt/β-catenin signaling, by restraining phosphorylation levels of β-catenin and expression levels of downstream targets.
CONCLUSIONS: In summary, this research indicates that miR-596 overexpression could be potentially useful in the cell growth and migration of prostatic cancer and serves as a potential molecular marker in prostatic cancer.

Entities:  

Keywords:  Migration; Proliferation; Prostatic cancer; miR-596; β-catenin

Mesh:

Substances:

Year:  2021        PMID: 33387246     DOI: 10.1007/s12094-020-02536-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  9 in total

1.  miR‑138 modulates prostate cancer cell invasion and migration via Wnt/β‑catenin pathway.

Authors:  Zhongwei Yu; Zulin Wang; Feng Li; Jiping Yang; Laikun Tang
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

2.  Incidence of prostate cancer at a single tertiary care center in North Karnataka.

Authors:  S C Ghagane; R B Nerli; M B Hiremath; A T Wagh; P V Magdum
Journal:  Indian J Cancer       Date:  2016 Jul-Sep       Impact factor: 1.224

3.  The long noncoding RNA LINC01207 promotes proliferation of lung adenocarcinoma.

Authors:  Gongchao Wang; Hongbo Chen; Jun Liu
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

4.  Inhibitory effects of Schisandrin B on human prostate cancer cells.

Authors:  Moussa Ide Nasser; Tingyu Han; Salah Adlat; Yuxin Tian; Nan Jiang
Journal:  Oncol Rep       Date:  2018-10-15       Impact factor: 3.906

5.  Exploration of Alternative Mechanism for MiR-596-mediated Down-regulation of LGALS3BP in Oral Squamous Cell Carcinoma.

Authors:  Hui Li
Journal:  Kokubyo Gakkai Zasshi       Date:  2015-07

6.  miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2.

Authors:  Yuanshan Yao; Yinjie Zhou; Xiaojun Fu
Journal:  Mol Med Rep       Date:  2019-01-15       Impact factor: 2.952

7.  MiR-26b regulates 5-FU-resistance in human colorectal cancer via down-regulation of Pgp.

Authors:  Bin Wang; Fen-Ying Lu; Rui-Hua Shi; Ya-Dong Feng; Xiao-Dan Zhao; Zhi-Ping Lu; Long Xiao; Guo-Qiang Zhou; Jia-Ming Qiu; Cui-E Cheng
Journal:  Am J Cancer Res       Date:  2018-12-01       Impact factor: 6.166

8.  MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.

Authors:  Weiqi Yin; Junfeng Chen; Guoyao Wang; Dongxu Zhang
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952

9.  MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.

Authors:  Lijuan Zhang; Tao Zhang; Zerun Deng; Lihua Sun
Journal:  Oncol Rep       Date:  2019-01-16       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.